The regulated secretory pathway is a specialized form of protein secretion found in endocrine and neuroendocrine cell types. Pro-opiomelanocortin (POMC) is a pro-hormone that utilizes this pathway to be trafficked to dense core secretory granules (DCSGs). Within this organelle, POMC is processed to multiple bioactive hormones that play key roles in cellular physiology.
INTRODUCTION
In addition to the constitutive secretion of proteins into the extracellular milieu, endocrine and neuroendocrine cells also possess a specialized form of secretion termed "regulated secretion" [1] [2] [3] . Interestingly, regulated secretion is often preceded by the specific targeting of unprocessed pro-hormones to a specialized subcellular storage organelle termed the dense core secretory granule (DCSG) [4, 5] . Within DCSGs, pro-hormones and their substrates can be processed into their active forms. Upon receiving the appropriate physiological stimulus, vesicles containing DCSG resident cargo fuse with the plasma membrane, and are secreted into the extracellular milieu [5] .
Pro-opiomelanocortin (POMC) is a pro-hormone that undergoes proteolytic cleavage to produce smaller active peptide hormones within DCSGs [6] [7] [8] . This activity requires the co-targeting of both POMC, and pro-hormone convertase (PC) enzymes to DCSGs where they mediate the conversion of POMC to its active forms ( [9] and reviewed in [10] ). The products generated from POMC cleavage by PCs include peptide hormones, such as α /β/γ melanotropin; which regulate skin pigmentation [11] , β -endorphin; an endogenous opioid [12] , and adrenocorticotropic hormone (ACTH); a key mediator in hypothalamic-pituitary-adrenal signaling [13] .
Multiple membrane trafficking proteins have been described as playing distinct roles in the sorting and processing of peptide hormones, however it remains unknown if these proteins affect the sorting of POMC to DCSGs. A critical membrane trafficking protein family is the heterotetrameric adaptor proteins (APs), AP-1 and AP-3, which mediate keys stages of DCSG formation and release [14] . Indeed, AP-1 is critical in selectively removing cargo from the maturing DCSGs, such as the vesicular associated membrane protein-4 (VAMP4) [15] , calcium independent-mannose-6-phosphate receptor (CI-MPR) [16] and furin [17] . Furthermore, knockdown of the AP-3δ subunit in C. elegans results in defects in DCSG density, size, and number [18] . Interestingly, the regulation of AP-1 and AP-3 relies on their ability to interact with the multifunctional membrane trafficking regulator phosphofurin acidic cluster sorting protein 1
(PACS-1) [19] . Specifically, the PACS-1:AP-1 interaction is mediated through PACS-1 residues 174-182, and facilitates the removal of VAMP4 from immature secretory granules through the VAMP4 cytoplasmic tail motif (E 27 DDSDEEED) [15, 19] . Furthermore, sorting of the cellular endopeptidase furin away from maturing secretory vesicles is mediated through PACS-1 and AP-1 [17] . Thus, through its ability to regulate AP-mediated trafficking, PACS-1 regulates multiple membrane trafficking steps within the cell, making it a hub for membrane trafficking, including cargo in the regulated secretory pathway.
Herein, we provide evidenced that identifies PACS-1 and AP-1 as key mediators in the sorting of POMC to the regulated secretory pathway. We observed that mutation of the PACS-1: AP binding site decreases the ability of PACS-1 to co-localize with ACTH-positive DCSGs.
Furthermore, knockdown of PACS-1 and AP-1 decreases DCSG formation, decreases intracellular ACTH storage, and increases extracellular ACTH levels in the absence of stimuli.
Importantly, upon knockdown of PACS-1 and AP-1, we observed an increase in ACTH localization to the constitutive secretory pathway.
MATERIALS AND METHODS

Cell Culture
AtT-20 cells (ATCC; catalog #CCL-89) were cultured in complete Dulbecco's Modified Eagle's Medium (DMEM; Hyclone, Logan, UT) supplemented with 10% fetal bovine serum (Wisent, Montreal, Canada), 10μM L-Glutamine (HyClone), and 100μM penicillin and streptomycin (Hyclone). Cells were grown at 37 °C in the presence of 5% CO 2 and sub-cultured in accordance with supplier's recommendations.
Plasmids and siRNA
Plasmids encoding VAMP2-GFP-C3 and GFP-tagged transferrin receptor were obtained from 
qRT-PCR
AtT-20 cells were transfected with siRNA, as described above. Cells were collected 48 hours post transfection, and RNA was extracted using Ambion RNA extraction kit (Life Technologies).
First strand cDNA synthesis was performed using the Superscript III RT cDNA synthesis kit (Life Technologies). Subsequently, cDNA was subjected to quantitative PCR using the SensiFast 
Western Blots
To assess intracellular protein levels in siRNA transfected cells, forty-eight hours posttransfection cells were lysed on ice with lysis buffer (0.5M HEPES, Billerica, MA). Band intensities corresponding to peptides of 29 kDa, 26 kDa, and 9 kDa were quantified using the ImageQuant Studio software (LI-COR) and normalized to the actin loading control.
Extracellular ACTH Quantification
To quantify basal extracellular levels of ACTH, cells were transfected with siRNA, as above.
Forty-eight hours post transfection, cell culture media was removed and 250µl of fresh complete DMEM added. Cells were then incubated at 37°C for 2 hours. Subsequently, cell supernatants were collected and centrifuged at 10 000 x g to remove particulates and supernatants were subjected to MAGPIX analysis using the ACTH MILLIPLEX MAP mouse pituitary magnetic bead panel (Millipore, Etobicoke, Ontario).
Immunofluorescence
Widefield imaging microscopy using the Pearson's correlation coefficient from the ImageJ plugin JACoP, as described previously [21] .
Ground-state depletion imaging
Super-resolution imaging was performed as described previously [21] . Briefly, cells were mounted, and imaged in a depression slide containing 100mM cysteamine (Sigma Aldrich). All images were acquired using a Leica SR GSD microscope with a 100X/1.43 NA objective lens containing a 1.6X magnifier. GFP and AlexaFluor 647 fluorophores were excited using 488 nm and 647 nm laser lines respectively. Resulting images were quantified using the spatial association analysis MIiSR software, as previously described [21] (Available for download:
http://phagocytes.ca/miisr/).
Statistics
All statistics were conducted using the unpaired t-test or the one-way ANOVA with multiple comparisons where indicated using Graph Pad Prism (Graph Pad Software Inc., La Jolla, CA).
RESULTS AND DISCUSSION
PACS-1 and AP-1 promote intracellular storage of POMC
PACS-1 mediates trafficking of multiple proteins to and from the trans-Golgi network (TGN) through its ability to recruit AP-1 and AP-3 [19] . Thus, we sought to test for a role of PACS-1, AP-1, and AP-3 in the sorting of POMC to DCSGs by performing knockdown studies in mouse pituitary AtT-20 cells, which endogenously expresses POMC [6] . Transfection of siRNAs targeting the PACS-1, AP-1, or AP-3 genes resulted in approximately 50% knockdown relative to non-specific siRNA, as determined by qRT-PCR ( Fig. 1A ). Subsequent to siRNA transfection, intracellular levels of POMC and its intermediates were assessed using Western blotting (Fig.   1B ). Total intracellular POMC cleavage products were detected by Western blot using an antibody which detects residues 1-18 of ACTH, and were quantified using densitometry [22] ( Fig. 1C) . Strikingly, upon knockdown of PACS-1 or AP-1, we observed a 50% reduction in intracellular POMC-derived peptides compared to non-specific siRNA. However, knockdown of AP-3 did not significantly alter the intracellular storage levels of POMC (Fig. 1C) . Interestingly, the processing of POMC was not affected when PACS-1 or Adaptor Protein levels were reduced ( Fig. 1) . This is consistent with the notion that PACS-1 may mediate sorting of POMC-derived peptides following its cleavage by a PC enzyme. Alternatively, upon depletion of PACS-1 and AP-1; PCs and POMC may mis-localize to the same compartment, wherein POMC can still be cleaved into active components, yet is secreted in an unregulated fashion. We next sought to determine if knockdown of PACS-1, AP-1 or AP-3 resulted in the increased secretion of the POMC-derived peptide ACTH, in the absence of external stimulation. We observed 1.5 fold and 1.25 fold increases in ACTH in the cell culture supernatant upon knockdown of PACS-1 and AP-1, respectively, compared to the non-specific control siRNA by MAGPIX analysis (Fig. 1D ). In contrast, increased levels of extracellular ACTH were not detected in cell culture supernatants from AP-3 knockdown cells (Fig. 1D) . These findings indicate that upon knockdown of PACS-1 or AP-1, unregulated secretion of ACTH occurs, suggesting that sorting of POMC to the regulated secretory pathway is dependent on the membrane trafficking proteins PACS-1 and AP-1, but not necessarily AP-3.
To further assess the role of PACS-1 and its binding partners AP-1 and AP-3 in the sorting of POMC-derived peptides to DCSGs, we visualized the localization of ACTH in AtT-20 cells using widefield microscopy ( Fig. 2A) . Accordingly, we co-transfected siRNA against PACS-1, AP-1, AP-3 or a non-specific sequence with a plasmid expressing a fluorescently labeled marker of the unregulated secretory pathway, the transferrin receptor (TfnR) [23] , and examined the cells via microscopy ( Fig. 2A) . We subsequently compared the co-localization of POMC/ACTH with TfnR-GFP [23] in the presence or absence of siRNA targeting the various trafficking 
ACTH is not directed to a lysosomal degradation pathway
We next tested if the reduced intracellular storage of POMC-derived peptides upon PACS-1 and AP-1 silencing could be attributed to the trafficking of POMC molecules to a degradative lysosomal compartment. To assess this, we analyzed ACTH co-localization with the lysosomal marker LAMP-1 in the presence of PACS-1, AP-1, AP-3 or control siRNA (Fig. 2C ). Co-localization analysis between LAMP-1 and ACTH revealed that decreased expression of PACS-1, AP-1 or AP-3 does not result in the trafficking of ACTH to a lysosomal compartment, compared to control siRNA (Fig. 2D ). Taken together, these results suggest that the observed decrease in intracellular storage of POMC-derived peptides is not driven through the degradation of ACTH. Co-localization between LAMP1 and ACTH staining was scored by calculating the mean (+/standard error) Pearson's correlation coefficient by quantification of at least 40 cells in 3 independent experiments. (n.s. represents not significant, LAMP1; Lysosomal associated membrane protein -1).
PACS-1: Adaptor Protein interactions modulate PACS-1:ACTH co-localization
Both PACS-1 and AP-1 act in concert to recognize cargo and modulate their localization within cells. For example, expression of a dominant-negative form of PACS-1, which is defective in AP-1/3 binding (termed ADMUT; Adaptor Protein binding Mutant), alters AP-1 localization, preventing furin trafficking from endosomes to the TGN [19] . Therefore, we sought to determine if PACS-1 co-localized with POMC-positive vesicles in an AP-dependent manner. To test this, we examined co-localization between PACS-1/ADMUT and ACTH through super-resolution ground-state depletion microscopy (GSDM) using nearest neighbor spatial association analysis [24, 25] (SAA; Fig. 3A, B and C) . GSDM allows for a 10-fold increase in resolution compared to conventional widefield or confocal microscopy [25] . Interestingly, we observed that over 60% of ACTH co-localized with PACS-1-GFP ( Fig. 3A and D) . Furthermore, SAA revealed that this co-localization occurred at a much greater rate than expected of randomly positioned molecules, suggesting that PACS-1 is within close proximity to ACTH vesicles, whereby it may be exerting its sorting function ( Fig. 3C and D) . Upon expression of ADMUT-GFP we observed a 30% reduction in co-localization of ACTH and ADMUT-GFP compared to wildtype PACS-1-GFP, as determined via super-resolution nearest-neighbor analysis ( Fig. 3B and C) . These results are akin to previous findings which demonstrate PACS-1 as an important regulator furin trafficking to and from immature secretory granules in an AP-1 dependent manner [26] .
PACS-1 and AP-1 facilitate the trafficking of ACTH to DCSGs
We next sought to define if PACS-1 and APs specifically mediate the targeting of ACTH to DCSGs. To ascertain this, we used the vesicular associated membrane protein 2 (VAMP2) as a marker for DCSGs [27] . Due to the observed increase in constitutive secretion of ACTH upon knockdown of PACS-1 and AP-1 (Fig. 1D) , we investigated the ability of ACTH to be targeted to VAMP2 positive DCSGs in the presence or absence of siRNA targeting PACS-1, AP-1 or AP-3 (Fig. 4A) . Strikingly, upon knockdown of PACS-1, we observed a significant reduction in the ability of ACTH (red) to be localized to VAMP2-positive compartments (green) compared to the non-specific siRNA control ( Fig. 4A and B) , highlighting the role of PACS-1 in sorting ACTH to mature granules. Furthermore, knockdown of AP-1 but not AP-3 resulted in an even greater reduction of ACTH localization to VAMP2-positive compartments (Fig. 4A and B) . Taken together, the results demonstrate the importance of PACS-1 and AP-1 in sorting ACTH containing vesicles to mature secretory granules. Interestingly, knockdown of AP-3 has been associated with the routing of the DCSG-resident protein, secretogranin II, to the unregulated secretory pathway [18] . In agreement with these findings, we observed that knockdown of AP-3 resulted in an increase in ACTH localization to the constitutive pathway ( Fig. 2A) . However, we did not observe a corresponding decrease in sorting of ACTH into VAMP2 positive granules (Fig. 4B ), nor did we observe an increase in extracellular ACTH secretion upon AP-3 knockdown (Fig. 1D) . It is possible that AP-3 knockdown results in the compensation by other APs, or that ACTH does not follow the AP-3 dependent pathway previously described, as not all DCSGs contain the same cargo [28] . Overall, we provide evidence supporting the key role of PACS-1 and AP-1 in controlling peptide hormone storage within AtT-20 cells. Controlling the release of peptide hormones is an important physiological process, which requires multiple proteins. Studying how these proteins work together is fundamental to understanding how different pathways can be altered in homeostasis and disease.
